Biosimilar Clinical Development: Scientific Considerations and New Methodologies
CHF 149.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Menon, Sandeep M. (Pfizer, Cambridge, Massachusetts, USA) (Hrsg.) / D'Agostino, Sr., Ralph B. (Boston University, Massachusetts, USA) (Hrsg.) / Xu, Siyan (Novartis Institutes for Biomedical Research, Massachusetts, USA) (Hrsg.) / Jin, PhD, Bo (Hrsg.)
- ISBN: 978-1-4822-3169-4
- EAN: 9781482231694
- Produktnummer: 18104500
- Verlag: Apple Academic Press Inc.
- Sprache: Englisch
- Erscheinungsjahr: 2016
- Seitenangabe: 248 S.
- Masse: H16.5 cm x B24.3 cm x D1.6 cm 594 g
- Abbildungen: 31 Illustrations, color
- Gewicht: 594
- Sonstiges: Tertiary Education (US: College)
Über den Autor
Dr. Kerry B. Barker is the Vice-President and Head of Early Oncology Research Statistics at Pfizer, Dr. Sandeep Menon is the Vice-President and Head of Biostatistics Research and Consulting Center at Pfizer , Dr. Ralph D'Agostino is a professor of Mathematics and Statistics at Boston University, Dr. Siyan Xu is a senior principal biostatistician at Novartis and Dr.Bo Jin is the Director of Biostatistics in Early Oncology Research at Pfizer. All have been involved with biosimilars clinical development across all regions of the world.
Bewertungen
Anmelden